- Sharp decline in demand for PCR tests.
- Downturn in the global life science research market due to high inflation and interest rates.
- Flagging Chinese economy and geopolitical risks.
- Increased competition in the biopharmaceutical CDMO business.
- Risks inherent in the supply chain, such as global disruption of logistics.
TAKARA BIO INC.
Greenhouse gas emissions & sustainability report data
In its 2024 reporting, TAKARA BIO INC. disclosed greenhouse gas emissions of 14.0K t-CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
14.0K t-CO2e
2024
Water Usage
117.0K m3
2024
Waste
315 tons
2024
Energy Use
15.7K thousand kWh (electricity) + 3226 thousand m3 (city gas)
2024
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2024 | 14.0K t-CO2e |
| 2023-04 to 2024-03 | 14.2K t-CO2 (Scope 1 and 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced CO2 emissions per unit of revenue (emissions intensity) to 89% of that of fiscal 2019.
- Switched from single-sided aluminum pouches to aluminum-free pouches for some products.
- Promoted a switch from paper boxes to FSC-certified materials and materials using plant-based oil ink.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce CO2 emissions per unit of revenue (emissions intensity) by 50% from fiscal 2019 by fiscal 2026.
📅 Medium-term
- Achieve 100% double-sided aluminum-free packaging for one-sided aluminum-free packaging by fiscal 2026.
- Grow Reagents business by 7% annually (local currency basis).
🌱 ESG Focus Areas
WellnessSafetyEnvironmentHuman ResourcesGovernanceHuman RightsProcurementCommunity